ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
The Relationship Between Hemoglobin Levels and Proliferative Diabetic Retinopathy in Type 2 Diabetes Patients.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetic retinopathy (DR), particularly proliferative diabetic retinopathy (PDR), is a leading cause of blindness. This study aimed to evaluate the predictive value of hemoglobin (Hb) and direct bilirubin (DBil) for PDR progression. Methods: We retrospectively collected data from 1,496 T2DM patients with DR treated at the South District of the First People's Hospital of Hefei. Logistic regression, correlation analysis, restricted cubic spline models, and Mendelian randomization were used. Results: For each unit increase in Hb and DBil, the risk of PDR decreased by 4.4% and 29.1%, respectively. Restricted cubic spline analyses showed a non-linear association between Hb and PDR: the risk decreased with increasing Hb up to a turning point at approximately 133 g/L and then plateaued thereafter; a turning point of 2.67 µmol/L was identified for DBil. The combined diagnostic model of Hb and DBil yielded an AUC of 0.742 with sensitivity 54.5% and specificity 86.5%, indicating moderate discriminative ability. Subgroup analysis showed higher PDR prevalence with worsening anemia. Mendelian randomization suggested a possible association between genetically predicted anemia and higher PDR risk (OR 1.06, 95% CI 1.003-1.12). Conclusion: Lower Hb and DBil levels were associated with higher PDR prevalence in this hospitalized population. These findings reflect statistical associations and require confirmation in prospective, population-based studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.